Is Buprenorphine Maintenance Right for Me?
Ongoing buprenorphine (Suboxone) therapy is the gold standard office-based treatment for both prescription opioid and heroin use disorders. While many treatment providers prescribe patients short tapers of buprenrophine or no medication at all, the research is unambiguous: Patients who start buprenorphine therapy, stabilize on a therapeutic dose, and take their medication daily have better outcomes than patients who complete a short taper or attempt "abstinence-based" treatment.
What is Buprenorphine?
Buprenorphine is the primary active ingredient in Suboxone Films. By attaching to the same receptors as heroin and prescription opioids, it helps to prevent withdrawal symptoms and cravings. With cravings well-managed, patients are able to focus on their day-to-day lives. Unlike heroin and prescription opioids, buprenorphine is only a "partial agonist". That partial agonism is important for two reasons:
1) buprenorphine is not intoxicating for persons with opioid dependence;
2) it has a very low risk for fatal overdose unless it is combined with other drugs.
Clayton Behavioral's Buprenorphine
Clayton Behavioral's Buprenorphine Program includes the following components:
- Screening and assessment to make sure that the program is appropriate for you
- Monthly case management to help you develop a comprehensive plan of recovery and access services, resources, and recovery supports that might benefit you
- Monthly physician appointments to monitor your progress and adjust your medical plan as appropriate